Hosny Nasser Mohammed, Sherif Yousery E
Chemistry Department, Faculty of Science, Port-Said University, 23 December Street, Port-Said, Egypt.
Department of Chemistry, Faculty of Science and Arts, Ulla, Taibah University, Saudi Arabia; Clinical Pharmacology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Spectrochim Acta A Mol Biomol Spectrosc. 2015 Feb 5;136 Pt B:510-9. doi: 10.1016/j.saa.2014.09.064. Epub 2014 Oct 5.
Three new metal complexes derived from Pd(II), Ru(III) and Zr(IV) with (E)-2-amino-N-(1-(2-aminophenyl)ethylidene)benzohydrazide (2-AAB) have been synthesized. The isolated complexes were characterized by elemental analyses, FT-IR, UV-Vis, ES-MS, (1)H NMR, XRD, thermal analyses (TGA and DTA) and conductance. The morphology and the particle size were determined by transmittance electron microscope (TEM). The results showed that, the ligand coordinates to Pd(II) in the enol form, while it coordinates to Ru(III) and Zr(IV) in the keto form. A square planar geometry is suggested for Pd(II) complex and octahedral geometries are suggested for Ru(III) and Zr(IV) complexes. The optical band gaps of the isolated complexes were measured and indicated the semi-conductivity nature of the complexes. The anti-inflammatory and analgesic activities of the ligand and its complexes showed that, Ru(III) complex has higher effect than the well known drug "meloxicam".
合成了三种由钯(II)、钌(III)和锆(IV)与(E)-2-氨基-N-(1-(2-氨基苯基)亚乙基)苯甲酰肼(2-AAB)衍生的新型金属配合物。通过元素分析、傅里叶变换红外光谱、紫外可见光谱、电喷雾质谱、核磁共振氢谱、X射线衍射、热分析(热重分析和差示热分析)和电导率对分离得到的配合物进行了表征。通过透射电子显微镜(TEM)测定了其形态和粒径。结果表明,配体以烯醇形式与钯(II)配位,而以酮形式与钌(III)和锆(IV)配位。推测钯(II)配合物为平面正方形几何构型,钌(III)和锆(IV)配合物为八面体几何构型。测定了分离得到的配合物的光学带隙,表明这些配合物具有半导体性质。配体及其配合物的抗炎和镇痛活性表明,钌(III)配合物的效果优于著名药物“美洛昔康”。